- Home
- TECH vs PWR Comparison
TECH vs PWR Comparison
Compare TECH & PWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- PWR
- Stock Information
- Founded
- TECH 1976
- PWR 1997
- Country
- TECH United States
- PWR United States
- Employees
- TECH N/A
- PWR N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- PWR Engineering & Construction
- Sector
- TECH Health Care
- PWR Industrials
- Exchange
- TECH Nasdaq
- PWR Nasdaq
- Market Cap
- TECH 8.0B
- PWR N/A
- IPO Year
- TECH 1989
- PWR 1998
- Fundamental
- Price
- TECH $51.07
- PWR $273.03
- Analyst Decision
- TECH Buy
- PWR Strong Buy
- Analyst Count
- TECH 9
- PWR 20
- Target Price
- TECH $81.25
- PWR $317.61
- AVG Volume (30 Days)
- TECH 2.1M
- PWR 1.4M
- Earning Date
- TECH 04-30-2025
- PWR 05-01-2025
- Dividend Yield
- TECH 0.63%
- PWR 0.15%
- EPS Growth
- TECH N/A
- PWR 20.60
- EPS
- TECH 0.98
- PWR 6.03
- Revenue
- TECH $1,196,016,000.00
- PWR $23,672,795,000.00
- Revenue This Year
- TECH $8.28
- PWR $14.68
- Revenue Next Year
- TECH $8.92
- PWR $9.71
- P/E Ratio
- TECH $51.75
- PWR $45.28
- Revenue Growth
- TECH 4.46
- PWR 13.36
- 52 Week Low
- TECH $46.44
- PWR $227.08
- 52 Week High
- TECH $85.57
- PWR $365.88
- Technical
- Relative Strength Index (RSI)
- TECH 38.34
- PWR 55.56
- Support Level
- TECH $46.44
- PWR $227.08
- Resistance Level
- TECH $52.75
- PWR $277.70
- Average True Range (ATR)
- TECH 3.18
- PWR 13.07
- MACD
- TECH -0.24
- PWR 3.01
- Stochastic Oscillator
- TECH 32.26
- PWR 90.77
Stock Price Comparison Chart: TECH vs PWR
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.